[1]郭园园,张浩然,卓士铉,等.基于网络药理学及体外实验探讨桔梗皂苷D对肝癌细胞迁移侵袭的影响及相关机制[J].医学信息,2021,34(23):1-8.[doi:10.3969/j.issn.1006-1959.2021.23.001]
　GUO Yuan-yuan,ZHANG Hao-ran,ZHUO Shi-xuan,et al.Effects of Platycodin D on Migration and Invasion of Hepatocellular Carcinoma Cells Based on Network Pharmacology and In Vitro Experiments[J].Medical Information,2021,34(23):1-8.[doi:10.3969/j.issn.1006-1959.2021.23.001]
点击复制

基于网络药理学及体外实验探讨桔梗皂苷D对肝癌细胞迁移侵袭的影响及相关机制()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年23期
页码:
1-8
栏目:
出版日期:
2021-12-01

文章信息/Info

Title:
Effects of Platycodin D on Migration and Invasion of Hepatocellular Carcinoma Cells Based on Network Pharmacology and In Vitro Experiments
文章编号:
1006-1959（2021）23-0001-08
作者:
郭园园; 张浩然; 卓士铉; 等
（1.南京中医药大学医学院·整合医学学院，江苏 南京 210023；2.南京医科大学基础医学院，江苏 南京 211166）
Author(s):
GUO Yuan-yuan; ZHANG Hao-ran; ZHUO Shi-xuan; et al.
(1.School of Medicine and Holistic Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,Jiangsu,China;2.School of Basic Medical Science,Nanjing Medical University,Nanjing 211166,Jiangsu,China)
关键词:
桔梗皂苷D; 肝癌; 网络药理学; E-cadherin蛋白
Keywords:
Platycodin D; Liver cancer; Network pharmacology; E-cadherin protein
分类号:
R735.7
DOI:
10.3969/j.issn.1006-1959.2021.23.001
文献标志码:
A
摘要:
目的 基于网络药理学及体外实验方法探讨桔梗皂苷D（PD）对肝癌细胞迁移侵袭的影响及其潜在分子机制。方法 检索HERB、PharmMapper及GeneCards数据库预测药物与疾病相关靶标；Venn图构建药物与疾病共同作用靶标；Cytoscape软件建立疾病-药物-靶标相关网络；STRING数据库构建蛋白相互作用网络；Rstuio软件对药物-疾病共同靶标进行基因本体（GO）分析以及京都基因与基因组百科全书（KEGG）信号通路富集分析；CCK-8法检测PD对细胞增殖的作用并筛选出最适给药浓度；伤口愈合实验探究PD对细胞迁移能力的影响；Transwell实验检测PD对细胞迁移及侵袭能力的影响；Western Blot（WB）实验检测相关蛋白表达水平。结果 网络药理学显示，PD与肝癌转移过程共有43个共同靶标；GO分析显示，共同靶标的相关途径涉及到调节炎症反应、细胞焦点粘附、细胞-底物连接等关键环节；KEGG分析显示，涉及到的相关通路包括白介素-17信号通路、T细胞受体信号通路等。体外实验显示，PD能够有效抑制肝癌细胞的增殖、迁移及侵袭行为；WB实验显示，PD能够有效上调细胞粘附的关键标志物E-cadherin蛋白的表达。结论 PD可能是通过上调E-cadherin蛋白表达，正性调控细胞粘附的生物学过程，从而抑制肝癌细胞的迁移侵袭能力。
Abstract:
Objective To investigate the effect of platycodin D (PD) on the migration and invasion of hepatocellular carcinoma cells and its potential molecular mechanism based on network pharmacology and in vitro experimental methods.Methods Searched HERB, PharmMapper and GeneCards databases to predict drug-related targets; Venn diagram to build drug and disease targets; cytoscape software to establish disease-drug-target network; STRING database to construct protein interaction network; Rstuio software was used for gene ontology (GO) analysis of drug-disease common targets and enrichment analysis of Kyoto encyclopedia of genes and genomes (KEGG) signaling pathway; CCK-8 assay was used to detect the effect of PD on cell proliferation and the optimal concentration was selected. Wound healing experiment explored the effect of PD on cell migration ability; transwell assay was used to detect the effect of PD on cell migration and invasion; Western Blot (WB) experiment was used to detect the expression levels of related proteins.Results Network pharmacology showed that there were 43 common targets for PD and liver cancer metastasis. GO analysis showed that the related pathways of common targets involved key links such as regulating inflammatory response, cell focus adhesion, and cell-substrate connection. KEGG analysis showed that the involved pathways included interleukin-17 signaling pathway, T cell receptor signaling pathway, etc. In vitro experiments showed that PD could effectively inhibit the proliferation, migration and invasion of HCC cells. WB experiments showed that PD could effectively up-regulate the expression of E-cadherin protein, a key marker of cell adhesion.Conclusion PD may positively regulate the biological process of cell adhesion by upregulating E-cadherin protein expression, thereby inhibiting the migration and invasion ability of hepatocellular carcinoma cells.

参考文献/References:

[1]Jin M,Shi C,Li T,et al.Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system[J].Biomed Pharmacother,2020(129):110282.[2]刘宗超,李哲轩,张阳,等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2021,7(2):1-14.[3]Anwanwan D,Singh SK,Singh S,et al.Challenges in liver cancer and possible treatment approaches[J].Biochim Biophys Acta Rev Cancer,2020,1873(1):188314.[4]Tao W,Su Q,Wang H,et al.Platycodin D attenuates acute lung injury by suppressing apoptosis and inflammation in vivo and in vitro[J].Int Immunopharmacol,2015,27(1):138-147.[5]Hu JN,Leng J,Shen Q,et al.Platycodin D suppresses cisplatin-induced cytotoxicity by suppressing ROS-mediated oxidative damage, apoptosis, and inflammation in HEK-293 cells[J].J Biochem Mol Toxicol,2021,35(1):e22624.[6]Cho SY,Song CH,Lee JE,et al.Effects of Platycodin D on Reflux Esophagitis due to Modulation of Antioxidant Defense Systems[J].Evid Based Complement Alternat Med,2018(2018):7918034.[7]Khan M,Maryam A,Zhang H,et al.Killing cancer with platycodin D through multiple mechanisms[J].J Cell Mol Med,2016,20(3):389-402.[8]Zhang X,Zhai T,Hei Z,et al.Effects of Platycodin D on apoptosis, migration, invasion and cell cycle arrest of gallbladder cancer cells[J].Oncol Lett,2020,20(6):311.[9]Zhang Z,Zhao M,Zheng W,et al.Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, suppresses the growth and invasion of human oral squamous cell carcinoma cells via the NF-κB pathway[J].J Biochem Mol Toxicol,2017,31(9):e21934.[10]曹俊红,许雪梅,李潇,等.桔梗皂苷D对子宫内膜癌细胞凋亡和侵袭的影响[J].中国临床药理学杂志,2020,36(11):1535-1539.[11]Wu D,Zhang W,Chen Y,et al.Platycodin D inhibits proliferation, migration and induces chemosensitization through inactivation of the NF-κB and JAK2/STAT3 pathways in multiple myeloma cells[J].Clin Exp Pharmacol Physiol,2019,46(12):1194-1200.[12]Qiu Z,Li H,Zhang Z,et al.A Pharmacogenomic Landscape in Human Liver Cancers[J].Cancer Cell,2019,36(2):179-193.e11.[13]Sayiner M,Golabi P,Younossi ZM.Disease Burden of Hepatocellular Carcinoma: A Global Perspective[J].Dig Dis Sci,2019,64(4):910-917.[14]Xiong Y,Zhao Q,Gu L,et al.Shenqi Fuzheng Injection Reverses Cisplatin Resistance through Mitofusin-2-Mediated Cell Cycle Arrest and Apoptosis in A549/DDP Cells[J].Evid Based Complement Alternat Med,2018(2018):8258246.[15]童光武,高鹏.消癌平注射液联合榄香烯注射液治疗中晚期原发性肝癌的临床研究[J].现代药物与临床,2016,31(5):691-695.[16]Zeng YY,Zeng YJ,Zhang NN,et al.The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma[J].Molecules,2019,24(9):1697.[17]赵亚楠,胡仲冬,杨爱琳,等.龙血竭中双黄酮化合物HIS-4对人肝癌HepG2和SK-HEP-1细胞的抗肿瘤作用研究[J].中国中药杂志,2019,44(7):8.[18]Li X,Lin Z,Zhang B,et al.β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1[J].Sci Rep,2016(6):21010.[19]Li T,Chen X,Chen X,et al.Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells[J].Sci Rep,2016(6):37997.[20]Luan X,Gao YG,Guan YY,et al.Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway[J].Toxicol Appl Pharmacol,2014,281(1):118-124.[21]Li T,Tang ZH,Xu WS,et al.Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells[J].Eur J Pharmacol,2015(749):81-88.[22]Ahn KS,Hahn BS,Kwack K,et al.Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes[J].Eur J Pharmacol,2006,537(1-3):1-11.

相似文献/References:

[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
　XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Medical Information,2018,31(23):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
　CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Medical Information,2018,31(23):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
　IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Medical Information,2019,32(23):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
　XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Medical Information,2018,31(23):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[5]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
　LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Medical Information,2018,31(23):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[6]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的 相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
　LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Medical Information,2019,32(23):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[7]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
　ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Medical Information,2019,32(23):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[8]孙 逊.性化护理对肝癌患者CT引导下射频消融术后 负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
　SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Medical Information,2019,32(23):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[9]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
　XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Medical Information,2019,32(23):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[10]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
　LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Medical Information,2019,32(23):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]

更新日期/Last Update: 1900-01-01